// App-Quantinova.ai

2087 : Bevacizumab in combination with TMZ in patients with recurrent GBM: Final OS and PFS analysis.

Researchers

Presenter

  • Juan Manuel Sepulveda

Principal Investigators

  • Cristobal Belda-Iniesta

  • Gaspar Reynes

  • Oscar Gallego

  • Jose Manuel Ordonez

  • Beatriz La Orden

  • Carmen Balana

  • Miquel Gil

  • Pedro Perez Segura

  • Alfonso Berrocal

Medical Centers

  • Hospital De Sant Pau, Barcelona, Spain

  • Institut Catala dOncologia Badalona, Barcelona, SpainHospital Universitario La Fe, Valencia, SpainInstituto Catalan de Oncologia, Bellvitge, Spain

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Consorcio Hospital General Universitario de Valencia, Valencia, Spain

  • Hospital Clinico Universitario San Carlos, Madrid, Spain

  • Roche Farma, S.A., Madrid, Spain

  • Hospital U. La Paz (actually at Hospital Madrid Norte Sanchinarro), Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01115491

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved